Ionis Pharmaceuticals, Inc.
IONS
$43.03
$0.050.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -268.22M | -458.03M | -453.90M | -358.81M | -365.74M |
| Total Depreciation and Amortization | 21.61M | 21.74M | 21.99M | 22.34M | 22.43M |
| Total Amortization of Deferred Charges | 6.64M | 6.67M | 6.69M | 6.68M | 6.70M |
| Total Other Non-Cash Items | 148.90M | 132.89M | 133.66M | 112.87M | 120.87M |
| Change in Net Operating Assets | -139.50M | -205.05M | -209.39M | -135.02M | -130.24M |
| Cash from Operations | -230.57M | -501.78M | -500.95M | -351.94M | -345.98M |
| Capital Expenditure | -59.44M | -53.36M | -45.28M | -18.96M | -12.05M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -162.76M | 13.69M | -88.75M | -209.99M | 192.60M |
| Cash from Investing | -222.19M | -39.67M | -134.03M | -228.95M | 180.55M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -44.68M | -44.67M | -44.67M | -164.00K | -67.95M |
| Issuance of Common Stock | 500.05M | 501.36M | 522.73M | 563.06M | 70.70M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 31.84M |
| Cash from Financing | 455.38M | 456.69M | 478.06M | 562.90M | 34.58M |
| Foreign Exchange rate Adjustments | 691.00K | 73.00K | -273.00K | 543.00K | 41.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.31M | -84.70M | -157.19M | -17.46M | -130.80M |